In addition, it seems reasonable to speculate that the Dok-1 mediated inhibition of Erk1/2 could also predict the anti-atherogenic effects of ghrelin, given the high impact of elevated MAPK pathway in atherosclerosis [60], [61]. Here, MAPK3 is linked to atherosclerosis.